433 related articles for article (PubMed ID: 19058585)
1. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and clonal relatedness between community- and hospital-acquired methicillin-resistant Staphylococcus aureus from blood cultures.
Jung SI; Shin DH; Park KH; Shin JH
J Microbiol; 2006 Jun; 44(3):336-43. PubMed ID: 16820764
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
[TBL] [Abstract][Full Text] [Related]
5. Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting.
Draghi DC; Sheehan DF; Hogan P; Sahm DF
Diagn Microbiol Infect Dis; 2006 Jun; 55(2):129-33. PubMed ID: 16542812
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial resistance of methicillin-resistant Staphylococcus aureus in hospital environment and inpatients].
Wu AH; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):525-30. PubMed ID: 19024378
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus bacteremia in a teaching hospital.
Chi CY; Ho MW; Ho CM; Lin PC; Wang JH; Fung CP
J Microbiol Immunol Infect; 2007 Aug; 40(4):310-6. PubMed ID: 17712465
[TBL] [Abstract][Full Text] [Related]
8. Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Orrett FA
Jpn J Infect Dis; 1999 Dec; 52(6):238-41. PubMed ID: 10738361
[TBL] [Abstract][Full Text] [Related]
9. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
12. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates.
Smith K; Gemmell CG; Hunter IS
J Antimicrob Chemother; 2008 Jan; 61(1):78-84. PubMed ID: 17981834
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
Samra Z; Ofer O; Shmuely H
Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
Saravolatz LD; Pawlak J; Johnson LB
J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
[TBL] [Abstract][Full Text] [Related]
18. Community acquired methicillin resistant Staphylococcsus aureus: a new threat for hospital outbreaks?
Gupta N; Prakash SK; Malik VK; Mehndiratta PL; Mathur MD
Indian J Pathol Microbiol; 1999 Oct; 42(4):421-6. PubMed ID: 11127372
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired methicillin-resistant Staphylococcus aureus infections in a south Indian city.
Krishna BV; Patil AB; Chandrasekhar MR
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):371-4. PubMed ID: 15691139
[TBL] [Abstract][Full Text] [Related]
20. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
